Although most popular hospital urine pregnancy tests perform well in the first month after conception, a new study finds that many become significantly more likely to produce false-negative results after the fifth to seventh week of pregnancy.
CDC’s grant of more than $1.25 million to the College of American Pathologists will help laboratory professionals improve the delivery of patient testing guidelines and cancer reporting.
Carla Lira has been named associate publisher for Allied Media’s Plastic Surgery Practice and Clinical Lab Products. She previously managed west coast sales for the brands.
French IVD manufacturer Theradiag has entered into a new research partnership with the French National Center for Scientific Research to develop microRNA-based diagnostic and theranostic tools for rheumatoid arthritis.
Acquisition of IQuum’s unique products will enable Roche to quickly enter the point of care segment of molecular diagnostics.
Quest Diagnostics has launched a website to provide patients with direct access to their lab reports, as required under new rules announced by the US Department of Health and Human Services.
Chembio Diagnostics has announced plans to build a US sales and marketing team after notifying Alere of the termination of its US Stat-Pak distribution agreement.
Researchers at the University of Texas Southwestern Medical Center are developing a predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help.
Data released at the American College of Cardiology annual scientific sessions suggest that a diagnostic strategy using nuclear magnetic resonance technologies can improve cholesterol management and reduce incidence of cardiovascular events.
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.